Table 1.
Generation | Drugs | Spectrum of Activity
|
Anaerobes/Atypicals | |
---|---|---|---|---|
Gram Positive | Gram Negative | |||
First | Nalidixic acida Cinoxacin |
Minimal Gram-positive | Enterobacteriaceae | None |
Second | Ciprofloxacinb,c Levofloxacinb,d Enoxacin Fleroxacin Ofloxacin Lomefloxacin Norfloxacin Pefloxacin |
Methicillin-susceptible Staphylcoccus aureus, Streptococcus pneumoniae, Other streptococci | Enterobacteriaceae Pseudomonas aeruginosa Haemophilus spp., Neisseria spp., Moraxella catarrhalis | Legionella pneumophila, Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum, Mycobacterium spp |
Thirde | Gatifloxacin Grepafloxacin Sparfloxacin Temafloxacin |
Methicillin-susceptible S. aureus, S. pneumoniae, Listeria monocytogenes, Other streptococci | Enterobacteriaceae Haemophilus spp., Neisseria spp., Moraxella catarrhalis | Legionella pneumophila Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum Mycobacterium spp |
Fourth | Moxifloxacinb,f Trovafloxacin Gemifloxacin |
Methicillin-susceptible S. aureus, S. pneumoniae, Other streptococci | Enterobacteriaceae Haemophilus spp., Neisseria spp., Moraxella catarrhalis | Legionella pneumophila, Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum, Mycobacterium spp. Anaerobes |
Only indicated for urinary tract infections due to low systemic exposure.
Most commonly prescribed.
Greatest activity against Pseudomonas aeruginosa.
Greatest activity against Streptococcus pneumoniae.
Not available in the United States or removed from the market.
Additional activity against anaerobes.